Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays
NCT04289428 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-12-03
Summary
Evaluation of novel point of care Hepatitis B diagnostic assays.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Xpert® HBV DNA fingerstick point of care assay
Xpert® HBV DNA point of care assay from finger-stick whole blood
- DIAGNOSTIC_TEST
-
Point of Care ALT
Point of Care ALT from finger-stick whole blood
- DIAGNOSTIC_TEST
-
Xpert® HBV DNA point of care assay from dried blood spot
Xpert® HBV DNA point of care assay from dried blood spot
Sponsors & Collaborators
-
Kirby Institute
lead OTHER_GOV
Principal Investigators
-
Gail Matthews, MBBS · Kirby Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-31
- Primary Completion
- 2022-07-31
- Completion
- 2022-10-31
Countries
- Australia
Study Locations
More Related Trials
-
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
NCT00168194 ·Status: COMPLETED
-
Predictive Model for Prognosis of Chronic HBV Infection Mothers
NCT04805034 ·Status: UNKNOWN
-
The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus Infection
NCT03214302 ·Status: UNKNOWN ·Phase: NA
-
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment
NCT02348502 ·Status: UNKNOWN
-
Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease
NCT06372990 ·Status: RECRUITING
-
Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Virus (HDV) Using Capillary Blood on Blotting Paper (DBS)
NCT06649396 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?
NCT02799316 ·Status: UNKNOWN ·Phase: NA
-
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
NCT06550622 ·Status: RECRUITING
-
Arresting Vertical Transmission of Hepatitis B Virus
NCT03567382 ·Status: COMPLETED ·Phase: PHASE4
-
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
NCT06379334 ·Status: ACTIVE_NOT_RECRUITING
-
Real World Assessment of People Living With Chronic Hepatitis B in Australia
NCT04914611 ·Status: RECRUITING
-
Prevention for Mother-to-infant Transmission of HBV
NCT02312531 ·Status: COMPLETED ·Phase: NA
-
Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination
NCT02323308 ·Status: COMPLETED
-
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
NCT02148562 ·Status: UNKNOWN
-
Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage
NCT03909191 ·Status: COMPLETED
-
Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
NCT04170452 ·Status: UNKNOWN
-
Antigen-specific Immune Response to Hepatitis B Virus in Utero
NCT00845403 ·Status: UNKNOWN
-
Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens
NCT00552214 ·Status: COMPLETED ·Phase: NA
-
Australian Hepatitis and Risk Survey in Prisons
NCT05839522 ·Status: UNKNOWN
-
"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.
NCT07317011 ·Status: RECRUITING
-
Impact of Hepatitis B Vaccination on HBs Antigenemia
NCT03193775 ·Status: COMPLETED ·Phase: NA
-
New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
NCT06906016 ·Status: RECRUITING
-
Occult Hepatitis B Virus Infection and HBV Reactivation After Switching to Long Acting Therapy in Patients With HIV-1
NCT06728917 ·Status: NOT_YET_RECRUITING
-
The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
NCT01310062 ·Status: UNKNOWN
-
A Study to Evaluate Vaccines Against COVID-19 in the Real World
NCT04775056 ·Status: WITHDRAWN